Saad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ (@szusmani) 's Twitter Profile
Saad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ

@szusmani

Chief of Myeloma @MSKCancerCenter | Chair @ALLIANCE_org #mmsm Com | MD โ‰  Provider| @ASH_hematology @ASTCT @ASCO |married to @ZainabShd | #BMTsm #CARTsm #CureMM

ID: 83911786

linkhttps://www.mskcc.org/cancer-care/doctors/saad-usmani calendar_today20-10-2009 19:46:12

13,13K Tweet

11,11K Followers

635 Following

International Myeloma Foundation (@imfmyeloma) 's Twitter Profile Photo

Why Iceland? The IMF-supported iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) is the first large-scale screening study in the field, screening 80,000+ for precursors of MM in a bold effort to understand what causes it. #kNOwMyeloma

Myeloma Society (@myeloma_society) 's Twitter Profile Photo

๐ŸšจAttention IMS 2024 participants: Please download Bluesky to stay informed with the latest event updates. Follow us here โžก๏ธbsky.app/profile/myelomโ€ฆ.

๐ŸšจAttention IMS 2024 participants: Please download Bluesky to stay informed with the latest event updates. Follow us here โžก๏ธbsky.app/profile/myelomโ€ฆ.
Saad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ (@szusmani) 's Twitter Profile Photo

Join us for the Inaugural Kyle-Barlogie Memorial Sloan Kettering-Mayo Clinic Plasma Cell Disorders Symposium on November 22-23, 2024! This event isapproved for AMA PRA Category 1 Creditsโ„ข๏ธ ย  Register by October 25th for the early bird discount! We look forward to seeing you

Join us for the Inaugural Kyle-Barlogie Memorial Sloan Kettering-Mayo Clinic Plasma Cell Disorders Symposium on November 22-23, 2024! This event isapproved for AMA PRA Category 1 Creditsโ„ข๏ธ ย  
Register by October 25th for the early bird discount! We look forward to seeing you
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

Congrats Krina!! One of the most amazing and also kindest mentors we have in the #MMsm field! And both you and Robert Z. Orlowski have the best humor on early-morning callsโ€ฆ def need more of that especially when <8am PDT ๐Ÿคฃ

Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile Photo

At the Hill for ASTCT #ASTCTHillDay advocating for Accelerating Kid's access to Care Act (HR4758), ABC (caregiver) Act (HR8018) & NIH funding. Thank you Amy Klobuchar's team for supporting. #Minneasota

At the Hill for <a href="/ASTCT/">ASTCT</a> #ASTCTHillDay advocating for Accelerating Kid's access to Care Act (HR4758), ABC (caregiver) Act (HR8018) &amp; <a href="/NIH/">NIH</a> funding. Thank you <a href="/amyklobuchar/">Amy Klobuchar</a>'s team for supporting. #Minneasota
Muzaffar Qazilbash (@transplant_doc) 's Twitter Profile Photo

Clinical outcomes with ide-cel in older patients (also frail) with RRMM. N=75, age >/=65. No difference in ORR, PFS or OS compared to younger patients #bmtsm #mmsm Krina Patel Leyla Shune MD ashpublications.org/bloodadvances/โ€ฆ

Clinical outcomes with ide-cel in older patients (also frail) with RRMM. N=75, age &gt;/=65. No difference in ORR, PFS or OS compared to younger patients #bmtsm #mmsm <a href="/DrKrinaPatel/">Krina Patel</a> <a href="/leshune/">Leyla Shune MD</a>
ashpublications.org/bloodadvances/โ€ฆ
Hamza Hashmi (@hhashmi87) 's Twitter Profile Photo

Tune into this great Onco-Nephrology Symposium at Memorial Sloan Kettering Cancer Center in #NYC with a stellar line up of speakers Saad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ I will talking on CAR T in RRMM & renal disease #MSKNephCME #MSKCME #MMSM #CART #MedTwitter #MedOncTwitter #kidney #cancer #MedEd

Tune into this great Onco-Nephrology Symposium at <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> in #NYC with a stellar line up of speakers <a href="/szusmani/">Saad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ</a> I will talking on CAR T in RRMM &amp; renal disease #MSKNephCME #MSKCME #MMSM #CART #MedTwitter #MedOncTwitter #kidney #cancer #MedEd
Alliance for Clinical Trials in Oncology (@alliance_org) 's Twitter Profile Photo

For #TrialTuesday, Dr.MHB Dana-Farber leads a new trial Alliance for Clinical Trials in Oncology A062101 to test the combination of two approved drugs & one experimental drug in pts w/relapsed or refractory #multiplemyeloma. Visit bit.ly/Alliance-A0621โ€ฆ #NCI #NCTN Multiple Myeloma RF @IMFMyeloma #MMSM Myeloma Chat Multiple Myeloma Hub

For #TrialTuesday, <a href="/DrMHB1/">Dr.MHB</a> <a href="/DanaFarber/">Dana-Farber</a> leads a new trial <a href="/ALLIANCE_org/">Alliance for Clinical Trials in Oncology</a> A062101 to test the combination of two approved drugs &amp; one experimental drug in pts w/relapsed or refractory #multiplemyeloma. Visit bit.ly/Alliance-A0621โ€ฆ #NCI #NCTN <a href="/theMMRF/">Multiple Myeloma RF</a> @IMFMyeloma <a href="/MMSMChats/">#MMSM Myeloma Chat</a> <a href="/MM_Hub/">Multiple Myeloma Hub</a>